We have measured the partial pressure of isoflurane simultaneously in inspired gas (Pl iso ), end-expired gas (PE'/SJ, mixed-expired gas (PE iso 
and anaesthetic machines have been developed in which the administration of the agent is controlled by continuous measurement of the end-expired partial pressure [2] . Cromwell and colleagues [3] , in a study on healthy volunteers breathing subanaesthetic concentrations of isoflurane, found no significant end-expiratory to arterial partial pressure difference. However, the recently published studies of Frei and colleagues [4] and Dwyer and colleagues [5] have shown an arterial to end-expiratory partial pressure ratio, after equilibration, ranging from 0.79 to 0.86. This ratio can be explained partly by the effects of venous admixture and alveolar deadspace, which are known to be increased in the anaesthetized patient. However, our own preliminary studies [unpublished] suggested that this explanation was insufficient to account for the whole of the arterial to end-expiratory partial pressure gradient for isoflurane. Eger [1] has suggested that anaesthetics of high molecular weight might fail to achieve uniform mixing within the alveolus, resulting in an "ideal" alveolar-pulmonary end-capillary partial pressure difference. To test this hypothesis, we have measured this difference for isoflurane in a group of patients in whom we simultaneously measured the shunt and physiological deadspace according to the threecompartment model ( fig. 1 ). This enabled us to make an estimate of the likely effect of these factors on the end-expiratory-arterial partial pressure difference for isoflurane. In the course of these measurements, we have determined the mixed venous partial pressure of isoflurane, which has not been reported previously in man.
PATIENTS AND METHODS
With the approval of the Hospital Ethics Committee we studied six patients, aged between 57 and 79 yr, undergoing major elective vascular surgery, in whom placement of an arterial cannula and Swan-Ganz catheter was required for clinical reasons. Patients were premedicated and anaesthetized in a routine manner as dictated by the attending anaesthetist. Thiopentone 3-5 mg kg" 1 
was the induction agent
The relation between the end-expired and arterial partial pressures of inhaled anaesthetic agents is important for both theoretical and practical reasons.
In formulating the concept of MAC, the assumption is made that "the alveolar partial pressure is transmitted without change to the arterial blood" [1] . A cuffed tracheal tube was passed and a leak-proof seal obtained. Anaesthesia was maintained with nitrous oxide, 34-51% oxygen and isoflurane. After induction, over-pressure of isoflurane (not greater than 2 %) was maintained for not more than 5 min after induction. The inspired concentration was then held constant (range 0.5-0.8%) until blood samples had been taken (table I) . Ventilation was with a Manley MP3 ventilator using a minute volume of approximately 6 litre.
Inspired oxygen percentage was measured continuously in the inspiratory limb of the circuit using a Servomex OA 580 paramagnetic analyser. Inspired and end-expired isoflurane percentages were monitored using a Datex Capnomac (95 % response time 900 ms) and end-expired carbon dioxide percentage was measured using an Ohmeda 5200 CO 2 monitor (95 % response time 360 ms). The sampling lines for isoflurane and carbon dioxide analysis were attached to the catheter mount of the tracheal tube, on the machine side of a Pall BB22-15 breathing system filter and the outputs recorded continuously on a Kipp and Zonen BD9 twinchannel chart recorder. The volume of the filter (approximately 90 ml) was included in the deadspace calculations.
Definitive measurements of end-expired carbon dioxide and inspired and end-expired isoflurane were taken from the chart recorder. A slow ventilatory frequency (approximately 12 b.p.m. with an inspired to expired ratio of 1:4) was deliberately set to allow a plateau for both inspired and expired gas to be recorded. The recorded end-tidal Pco 2 bore the normal relation to the arterial Pco 2 and the recorded inspired Piso agreed closely with a genuine upstream inspired sample measured by gas chromatography. Under these conditions, we are confident that we had a valid end-expiratory sample.
Arterial and mixed venous blood samples were taken after at least 25 min of anaesthesia at a constant inspired isoflurane percentage, with the end-expired isoflurane percentage changing by not more than 0.02 % for at least 15 min. Blood samples for arterial and mixed venous pH, Po 2 , Pco 2 and oxygen saturation were obtained anaerobically in duplicate 2-ml, heparinized syringes, using three-way taps to clear the deadspace from both the arterial and pulmonary artery cannulae. Samples were stored on crushed ice for a maximum of 15 min before analysis using an IL 1302 blood-gas machine and an IL 282 Co-oximeter. Oxygen saturation of haemoglobin (So 2 ) was derived also from the virtual Po 2 (calculated for 37 °C) using the Severinghaus nomogram [6] . In all cases the calculated saturation agreed with the measured saturation to within 2% (corrected for carboxyhaemoglobin), the mean difference being 0.1%. Separate 5-ml blood samples were also obtained to measure arterial and mixed venous haemoglobin concentration and PCV (Coulter Counter model S). Oxygen content of arterial, mixed venous and pulmonary capillary blood was then derived as:
[Hb] x So 2 /100 x 1.31+0.0225 x Po 2 where [Hb] = haemoglobin concentration corrected for carboxyhaemoglobin; Po 2 was at 37 °C; 1.31 = haemoglobin combining factor obtained by Gregory [7] ; 0.0225 = solubility coefficient of oxygen in whole blood. The pulmonary end-capillary Po 2 was assumed to equal the alveolar Po 2 . This was derived from the Filley equation [8] which allows for nitrous oxide uptake.
Blood samples for measuring isoflurane partial pressure were obtained in gas-tight, heparinized, 2-ml all-glass syringes. Aliquots (0.5 ml) were then injected immediately through a Teflon seal into 2-ml glass vials with loosened screw caps; the caps were tightened immediately after injection. This procedure allowed the blood-gas mixture in the vial to remain at barometric pressure.
During the period of blood sampling, mixed expired gas was collected from the expiratory port of the patient ventilator into a Douglas bag for at least 3 min. After expired gas collection, two 20-ml and two 100-ml samples of inspired gas were obtained from the inspiratory limb of the patient ventilator, and two 20-ml and two 100-ml samples of mixed expired gas from the Douglas bag.
Barometric pressure, room temperature and the patient's tympanic membrane temperature (Mallinckrodt Mon-A-Therm) were noted at the time of sampling and the appropriate corrections made in calculations. Mixed expired gas samples (100 ml) were analysed in duplicate for oxygen, carbon dioxide and isoflurane by the same monitors used for inspired and end-expired gas analysis. The 20-ml samples of inspired and mixed expired gas were analysed for isoflurane by gas chromatography to cross-check measurements taken from the chart recorder. The mean (SEM) difference was 0.011 (0.009) kPa. The mean value was calculated and used for subsequent calculations.
Isoflurane partial pressures in blood samples were measured as described by Knill and colleagues [9] using a Pye 104 gas chromatograph (GC) fitted with a 60-|il or 500-ul gas sampling loop and a flame ionization detector. The carrier gas was oxygen-free nitrogen. Oven temperature was 125 °C and detector temperature was 175 °C. The blood-gas samples were equilibrated at 37 °C in a thermostatically controlled chamber by gentle rotation in a vertical plane at 20 r.p.m. for 45 min. A portion of the gas was then flushed into the gas sampling loop of the GC to obtain an isoflurane partial pressure and the remaining gas expelled. The same volume of unequilibrated humidified air was added to the vial and allowed to equilibrate as before. The procedure was repeated four times in total. The natural logarithms of the chromatogram peak heights from each of the four equilibrated gas phases were plotted against the serial number of the equilibration. Assuming that the partition coefficient of isoflurane is independent of absolute tension, these plots should fall on a straight line. The Y-intercept is proportional to the partial pressure of isoflurane in the original blood sample. Regression lines for each pair of samples were obtained using the least squares technique and the results averaged. The mean correlation coefficient for the series was -0.9958 (0.0025) and the coefficient of variation between duplicate samples was 2.1%.
To check the accuracy of our isoflurane measurements, 26 normal blood samples were tonometered in a gas flow of known isoflurane partial pressures (Piso). The partial pressure in the samples was determined as described above. The mean (SE) Piso in the gas phase was 0.241 (0.008) kPa and that in the blood samples 0.243 (0.008) kPa. The difference between paired analyses was not significant (t = 0.76).
Analytical equipment was calibrated before and after each study. The GC was calibrated using the same standard gas mixtures as those used for calibration of the Capnomac and the Ohmeda CO 2 monitor was calibrated against the same standard as that used for blood-gas analysis. The Servomex OA 580 was calibrated with oxygen-free nitrogen and room air. The Datex Capnomac, the Ohmeda CO 2 monitor, the Servomex paramagnetic analyser and GC were all checked for linearity before the study.
CALCULATIONS ( fig. 1) 
Dilution factor for end-expiratory gas
The inspired partial pressure of isoflurane, Pii so , was calculated as follows:
where Fi lso = fractional inspired concentration of isoflurane in dry gas; PB = barometric pressure; PH 2 O = saturated vapour pressure of water at body temperature.
On the assumption that the alveolar deadspace gas has the same composition as inspired gas, the dilution factor for end-expiratory gas by alveolar deadspace gas is:
where PA C02 = alveolar Pco 2 ; PE' C02 = end-expired Pco 2 ; Pl CO2 = inspired Pco 2 .
On the assumptions that Pa COi , = PA C O 2 and Pi cc > 2 = 0, then:
where Pa cc , 2 = arterial Pco 2 . Equation (1) was then applied to isoflurane and the ideal alveolar partial pressure of isoflurane was then derived as:
where PA iS0 = alveolar Piso; PE' ISO = end-expiratory Piso; Pi lso = inspired Piso.
Dilution factor for arterial blood
The shunt fraction was calculated using the classical shunt equation, deriving anerial and mixed venous oxygen content from So 2 , Po 2 and haemoglobin concentration as described above:
where Cc' Oi = pulmonary end-capillary blood oxygen content; Ca 02 = arterial blood oxygen content and Cv o = mixed venous blood oxygen content.
The shunt equation was applied to isoflurane and the pulmonary end-capillary partial pressure of isoflurane (Pc' 1S0 ) derived as:
p , _ P^iso -(shunt x Pv lso ) 150 1 -shunt where Pa ls0 = arterial Piso; Pv lso = mixed venous Piso. The data are shown as mean (SE) and where appropriate the difference between means was tested using Student's t test.
RESULTS
After 25 min with a constant inspired isoflurane concentration, a relatively steady state was achieved with the end-expired isoflurane concentration changing by less than 0.02 % during the last 15 min of this period, and by less than 0.01 % during the 5-min period of measurements. Inspired Piso was 0.69 (0.05) kPa and end-expiratory Piso was 0.52 (0.04) kPa, giving an end-expired: inspired ratio of 0.75 (0.02). Arterial Piso was 0.35 (0.03) kPa, with an arterial: end-expired ratio of 0.66 (0.02). Piso of the mixed venous blood was 0.22 (0.03) kPa (table I) .
At the time of the isoflurane measurements, the physiological deadspace (including apparatus deadspace) was 53.6 (3.1)%, and the arterial-endexpiratory Pco 2 difference 0.56 (0.16) kPa. Calculated for carbon dioxide, the dilution factor for alveolar gas by alveolar deadspace was 11.58 (3.39) %. The shunt fraction was 14.8 (4.74) %, with an ideal alveolar to arterial Po 2 gradient of 14.2 (2.21) kPa.
Derived values
Applying the alveolar deadspace dilution factor to isoflurane, the calculated ideal alveolar Piso would be 0.50 (0.04) kPa; this was 96 (1.0)% of the endexpired value, a difference between the two of only 0.02 kPa.
Applying the shunt fraction to isoflurane, the pulmonary end-capillary Piso would be 0.38 (0.04) kPa which is only 0.03 kPa greater than the arterial Piso. The residual, unexplained, difference between ideal alveolar Piso and pulmonary endcapillary Piso was 0.12 (0.01) kPa. The difference from zero for this gradient was highly significant (P < 0.001) ( fig. 2 ).
DISCUSSION
The presence of an end-expiratory to arterial anaesthetic partial pressure difference has been demonstrated for several volatile anaesthetic agents in healthy subjects. Our mean measured arterial: end-expired Piso ratio for isoflurane was 0.66 (0.02), which is less than the values obtained by Frei and colleagues [4] and Dwyer and colleagues [5] , but we are in full agreement that a substantial difference exists. This gradient has been attributed hitherto to the increased alveolar deadspace and venous admixture (shunt) found in anaesthetized patients [10] [11] [12] [13] [14] .
In the present study, the values for physiological deadspace and the arterial-end-expiratory Pco 2 difference were typical for anaesthetized patients with tracheal tube and apparatus deadspace included [15] . The alveolar deadspace dilution factor of 11.6 % can have little effect on the ideal alveolar-endexpiratory difference, partly because it is normally quite small during anaesthesia and partly because the alveolar deadspace gas would contain isoflurane approximating in composition to the inspired gas. Thus the ideal alveolar Piso is very little less than the measured end-expired value: only 0.02 kPa in the present study. Similar considerations would apply to ventilation of alveolar units of large (but not infinite) ventilation: perfusion ratio simulating a true alvolar deadspace. The mean shunt in this study accords very closely with previous observations on anaesthetized patients in the age range 57-79 yr [12] . If the threecompartment model is applied to isoflurane, the pulmonary end-capillary Piso would be only 0.03 kPa greater than the arterial Piso. This is to be expected because, in common with carbon dioxide, Piso bears a constant relation to content and the partial pressures in mixed venous and arterial blood are not greatly different. It is only because of its alinear dissociation curve that oxygen has so large an alveolar-arterial Po 2 difference in the presence of a shunt. Thus the corrections for shunt and deadspace together account for only 33% of the total endexpired to arterial Piso difference ( fig. 2, table I ).
Our analysis has followed the classical threecompartment model of the lung suggested by Riley and Cournand [16] . Although this approach treats relative maldistribution of ventilation and perfusion as though it contributed to alveolar deadspace and shunt, it gives values for these parameters which permit satisfactory prediction of arterial Pco 2 and Po 2 in a wide range of clinical situations. In this analysis some approximations are made, and it remains to consider how these effect the validity of our conclusions.
The Riley analysis assumes that the alveolar deadspace gas contains gas which has the same composition as inspired gas. In fact, a small quantity of end-expiratory gas from the anatomical deadspace must be re-inhaled into the alveolar deadspace. If, as seems likely, this effect were to increase the Pco 2 of the alveolar deadspace gas by 0.4 kPa, then the mean value for the alveolar deadspace dilution factor would be increased by about 0.9% (equation (1)). This would result in a reduction in the calculated ideal alveolar Piso of about 0.002 kPa (equation (2)). However, the Riley analysis also assumes that ideal alveolar Pco 2 equals arterial Pco 2 . This is not so when there is an appreciable shunt, but the effect is usually very small because the mixed venous-arterial Pco 2 difference is normally only about 10 % of the arterial-mixed venous Po 2 difference, and much less when the concentration of oxygen in the inspired gas is increased. A mean shunt of 14.8%, with our measured values for mean arterial and mixed venous Pco 2 , would reduce the mean ideal alveolar Pco 2 from an assumed 4.9 kPa to 4.8 kPa. Substitution of the corrected value into equation (1) reduces the mean alveolar deadspace dilution factor by about 2%, increasing the calculated ideal alveolar Piso by about 0.004 kPa. This offsets the previous correction and the net result is a very small increase (0.002 kPa) in the calculated ideal alveolar Piso.
Calculation of shunt in the Riley analysis depends on the value for ideal alveolar Po 2 , which is derived from the ideal alveolar Pco 2 , conventionally assumed to be equal to the arterial Pco 2 . Applying the correction to the alveolar Pco 2 derived in the previous paragraph, the calculated shunt would be decreased by less than 0.1%. This would increase the derived pulmonary end-capillary Piso by a negligible quantity-less than 0.0002 kPa. This would have no significant effect on the residual gradient.
Anaesthesia results in compression atelectasis of dependent lung zones, with a true shunt which relates to the amount of atelectasis observed by computed tomography [17] . However, during anaesthesia about 50% of the observed alveolar to arterial Pco 2 difference and the venous admixture (calculated from the shunt equation) is explained by an increased spread of ventilation: perfusion ratios and, in particular, as a result of perfusing alveolar units with ventilation: perfusion ratios in the range 0.005-0.1 [11, 12, 18] . This has a much greater effect on Po 2 than on either Pco 2 or Piso because of the upward convexity of the oxyhaemoglobin dissociation curve. However, this factor is considered in calculating the equivalent "shunt effect" of perfusion in areas of low ventilation: perfusion ratios.
Dueck and colleagues [19] have argued that the method of analysing VA/Q relations in the lungs used by Nunn, Bergman and Coleman [12] and in our present study has limitations because calculated shunt increases with smaller inspired oxygen concentration. However, the range of fractional inspired concentrations of oxygen used in our study was 0.34-0.50 and it is likely that most of the calculated venous admixture represents true shunt. Even if our calculations of shunt are underestimates, a large shunt, in the region of 50%, would be required to explain the observed end-expired-arterial Piso difference. In spite of the limitations of the threecompartment model, it seems improbable that abnormal distribution of ventilation: perfusion ratios, sufficient to cause the observed alveolar-arterial Po 2 difference, could explain more than a small fraction of the observed end-expiratory-arterial Piso difference.
If there is indeed a finite ideal alveolar-pulmonary end-capillary Piso difference, there are two possible explanations: there could be resistance to transfer through the alveolar capillary membrane; or isoflurane may not achieve uniform distribution throughout the alveoli during the ventilatory cycle. It is difficult to say how the physical properties of isoflurane could influence its ease of passage through the alveolar-capillary membrane. There is no measurable impairment of oxygen or carbon dioxide, except under conditions of maximal exercise at decreased inspired Po 2 . For isoflurane, both water and lipid solubilities are greater than those of oxygen, which should favour its passage through the membrane. However, its molecular weight is much greater.
Gas mixing within the alveoli occurs predominantly by diffusion and the rate at which a gas diffuses is inversely proportional to the square root of its molecular weight. Under normal circumstances, incomplete mixing of gases such as oxygen and carbon dioxide is unlikely to occur. The average diameter of the human alveolus at functional residual capacity is about 200 um and it is likely that mixing of gases of low molecular weight is almost instantaneous over the very small distance from the centre to the periphery [20] . However, this may not be the case for isoflurane or other anaesthetics of relatively high molecular weight. Georg and colleagues [21] studied diffusion differences in the gas phase of the lungs of normal and emphysematous subjects using three inert gases of widely different molecular weights and found that the ratio of heavier to lighter gas varied with the volume of expired gas. These differences were exaggerated in emphysematous subjects. Further evidence that the changes in ratio are the result of differing rates of gas diffusion comes from breath-holding experiments: when a breath is held for 30 s the ratios in the expired gas are independent of the volume expired [22] . Robertson, Whitehead and Hlastala [23] observed a difference in the retention of isoflurane (184.5 Da) and acetylene (26 Da) during its passage from blood to expired air. This could not be explained by differences in partition coefficients, and they concluded that it was consistent with a diffusion-related impairment of gas exchange. In support of this view, they cited several authors who had reported differences in anatomical deadspace as measured with gases of markedly different molecular weight.
This evidence suggests that some volatile anaesthetics may not be uniformly distributed throughout the alveolus and these inhomogeneities may make some contribution to the gradient between ideal alveolar gas and pulmonary end-capillary blood. It is likely that this gradient will differ for different anaesthetics. For nitrous oxide, Eger and colleagues [24] found a Pa:PE' ratio of 0.98 after 8 min, implying that when deadspace and shunt have been accounted for, there is no residual gradient.
Our results and those of Frei and colleagues [4] and Dwyer and colleagues [5] show clearly that endexpiratory partial pressures of some volatile anaesthetics are greater than those in arterial blood, and must be greater than at the site of action in the brain. Thus MAC is related to values which differ significantly from those at the site of action. Nevertheless, it is not possible to measure partial pressures at the site of action, nor is it feasible to monitor arterial partial pressure in the present state of technology. It is therefore fortunate that the arterial: end-expiratory Piso ratio was found to be remarkably constant at 0.66 (0.02). Thus measuring end-expiratory partial pressures in relation to MAC values is a valid method to monitor the depth of anaesthesia. However, comparison of MAC values as an absolute measure of potency might be questioned if the arterial: end-expired ratios are significantly different, as seems to be the case at least for nitrous oxide and isoflurane.
To our knowledge, mixed venous concentrations of an anaesthetic have not been measured before in humans and on average they were 40 % smaller than the arterial value. However, it can be predicted that, in humans, it would take several days of anaesthesia for the mixed venous concentration of isoflurane to equal that of arterial blood, when the inspired-endexpiratory-arterial gradient would disappear. The presence of this gradient for isoflurane is therefore likely to persist even during prolonged anaesthesia.
In conclusion, we suggest that the effects of shunt and deadspace are small and the main reason for the end-expired to arterial partial pressure gradient for isoflurane observed by Frei and colleagues [4] , Dwyer and colleagues [5] and ourselves may be the failure to achieve uniform distribution within the alveolus. This will impede changes in anaesthetic partial pressure in blood and therefore tissues, thus hindering the attainment and reversal of the anaesthetic state. Further studies on other volatile anaesthetics are needed.
